Search Within

Guido Dalbagni

  1. "Biostatistics Service"
Formats
  1. Journal Article (24)
  2. Meeting Abstract (17)
  3. Correspondence (5)
  4. Conference Paper (1)
Groups
  1. Biostatistics Service (47)
  2. Epidemiology and Biostatistics (47)
  3. Surgery (47)
  4. Urology (47)
  5. Department of Medicine (34)
  6. Genitourinary Oncology Service (34)

More Groups

People
  1. Bernard Bochner (39)
  2. Dean Bajorin (29)
  3. Jonathan Rosenberg (29)
  4. Irina Ostrovnaya (26)
  5. Gopakumar Iyer (23)
  6. Hikmat Al-Ahmadie (21)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (4)
  4. 2022 (4)
  5. 2021 (4)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (11)
  2. Journal of Urology (8)
  3. European Urology (4)
  4. Cancer (2)
  5. Clinical Genitourinary Cancer (2)
  6. JCO Precision Oncology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (13)
  2. Elsevier Science, Inc. (13)
  3. American Association for Cancer Research (4)
  4. Elsevier Inc. (4)
  5. Nature Publishing Group (3)
  6. Wiley Blackwell (3)

More Publishers

Results (47)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Correlative science from a phase I study of intravesical Fc-optimized anti-CD40 agonist antibody 2141-V11 for non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guerin (BCG)
    Meeting Abstract

    Bochner, B. H.; Alam, S. M.; Blanchard, L.; Yao, N.; Angulo-Lozano, J.; Wong, J.; Knorr, D.; Whiting, K.; Seshan, V.; Donahue, T.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Natural history and genomic landscape of chemotherapy-resistant muscle-invasive bladder cancer
    Journal Article

    Lenis, A. T.; Whiting, K.; Ravichandran, V.; Tallman, J. E.; Alam, S. M.; Chu, C. E.; De Jesus Escano, M.; Bochner, E.; Katims, A.; Reisz, P. A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Development of a genomic prediction model for upper tract urothelial carcinoma stage
    Meeting Abstract

    Katims, A. B.; Lavery, J. A.; Ostrovnaya, I.; Bochner, B. H.; Dalbagni, G.; Donahue, T. A.; Donat, S. M.; Herr, H. W.; Pietzak, E. J.; Al-Ahmadie, H.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Health-related quality of life after robotic-assisted vs open radical cystectomy: Analysis of a randomized trial. Reply
    Correspondence

    Clements, M. B.; Beech, B. B.; Atkinson, T. M.; Dalbagni, G. M.; Li, Y.; Vickers, A. J.; Herr, H. W.; Donat, S. M.; Sjoberg, D. D.; Tin, A. L.; more...
    Journal of Urology (2023)

    Fulltext@MSK | Save
  • Reply by authors
    Correspondence

    Clements, M. B.; Beech, B. B.; Atkinson, T. M.; Dalbagni, G. M.; Li, Y.; Vickers, A. J.; Herr, H. W.; Donat, S. M.; Sjoberg, D. D.; Tin, A. L.; more...
    Journal of Urology (2023)

    Fulltext@MSK | Save
  • Health-related quality of life after robotic-assisted vs open radical cystectomy: Analysis of a randomized trial
    Journal Article

    Clements, M. B.; Beech, B. B.; Atkinson, T. M.; Dalbagni, G. M.; Li, Y.; Vickers, A. J.; Herr, H. W.; Donat, S. M.; Sjoberg, D. D.; Tin, A. L.; more...
    Journal of Urology (2023)

    Fulltext@MSK | Save
  • Neoadjuvant nivolumab (N) + ipilimumab (I) in cisplatin-ineligible patients with upper tract urothelial cancer (UTUC)
    Meeting Abstract

    Teo, M. Y.; Guercio, B. J.; Pietzak, E. J.; Ponomarev, M.; Regazzi, A. M.; Quinlan, C.; Aggen, D. H.; Donahue, T. F.; Goh, A. C.; Cha, E. K.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical and genomic characterization of bladder carcinomas with glandular phenotype
    Journal Article

    Almassi, N.; Whiting, K.; Toubaji, A.; Lenis, A. T.; Jordan, E. J.; Won, H.; Regazzi, A. M.; Chen, Y. B.; Gopalan, A.; Sirintrapun, S. J.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Phase I study of intravesical anti-CD40 agonist antibody 2141-V11 for non-muscle invasive bladder cancer unresponsive to Bacillus Calmette-Guerin (BCG) therapy
    Meeting Abstract

    Wong, J. L.; Knorr, D.; Whiting, K.; Seshan, V. E.; Pietzak, E. J.; Donahue, T. F.; Cha, E. K.; Goh, A. C.; Smith, R.; Dalbagni, G.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Long-term outcomes of local and metastatic small cell carcinoma of the urinary bladder and genomic analysis of patients treated with neoadjuvant chemotherapy
    Journal Article

    Teo, M. Y.; Guercio, B. J.; Arora, A.; Hao, X.; Regazzi, A. M.; Donahue, T.; Herr, H. W.; Goh, A. C.; Cha, E. K.; Pietzak, E.; more...
    Clinical Genitourinary Cancer (2022)

    Fulltext@MSK | Save